ReviewFrontiers in immunology2025

Combination of PD-1/PD-L1 and CTLA-4 inhibitors in the treatment of cancer - a brief update.

Johan Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.